Detalhe da pesquisa
1.
The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma.
Eur Respir J
; 63(4)2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453256
2.
Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial.
J Allergy Clin Immunol
; 150(4): 830-840, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537502
3.
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions.
Eur Respir J
; 54(3)2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467120
4.
In vitro, in silico and in vivo study challenges the impact of bronchial thermoplasty on acute airway smooth muscle mass loss.
Eur Respir J
; 51(5)2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700102
5.
Bronchial thermoplasty: what we know, what we don't know, and what we need to know.
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972685
6.
Pathogenesis of asthma: implications for precision medicine.
Clin Sci (Lond)
; 131(14): 1723-1735, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28667070
7.
Comment on "Unraveling a Clinical Paradox: Why Does Bronchial Thermoplasty Work in Asthma?"
Am J Respir Cell Mol Biol
; 61(5): 660-661, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31674824
8.
Outcome measures in asthma attack trials: can't see the good for the wheeze.
ERJ Open Res
; 10(1)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410716
9.
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial.
Lancet Respir Med
; 10(5): 469-477, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339234
10.
Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report.
Chest
; 158(1): 68-96, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31972181
11.
Cough and Eosinophilia.
J Allergy Clin Immunol Pract
; 7(6): 1740-1747, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279462
12.
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
Lancet Respir Med
; 6(7): 499-510, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29793857